Elanco Animal Health Inc (ELAN) earnings date

NYSE · Large cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 37 days, typically, give or take 9 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Fri, Nov 6, 2026before open 37 8-K
Q2 FY2026Wed, Aug 5, 2026before open 36 8-K
Q1 FY2026Wed, May 6, 2026before open 36 8-K
Q4 FY2025Tue, Feb 24, 2026before open 55 8-K
Q3 FY2025Wed, Nov 5, 2025before open 36 8-K
Q2 FY2025Thu, Aug 7, 2025before open 38 8-K
Q1 FY2025Wed, May 7, 2025before open 37 8-K
Q4 FY2024Tue, Feb 25, 2025before open 56 8-K

What they guided beta

Q3 FY2026 "Document Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact: Tiffany Kanaga (765) 740-0314 or tiffany.kanaga@elancoah.com Media Contact: Colleen Parr Dekker (317) 989-7011 or colleen.dekker@elancoah.com Elanco Animal Health Reports Third Quarter 2026 Results Accelerated Price, Organic Constant Currency Revenue Growth, and Gross Margin Expansion; Raising Full Year Outlook and Innovation Target; Achieved 2.9x Net Leverage Ratio Milestone" exhibit
Q3 FY2026 "Building on expectations for full year 2026 outperformance, with continued expectation for 2027 results in line with December 2025 Investor Day annual algorithm: mid-single digit organic constant currency revenue growth, high-single digit Adjusted EBITDA growth, and low-double digit Adjusted EPS growth Indianapolis, IN ( November 6, 2026 ) - Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the third quarter of 2026, provided guidance for the fourth quarter of 2026, updated guidance for the full year 2026, and provided an early outlook for the full year 2027." exhibit
Q3 FY2026 "As we are raising fu ll-year guidance to fully pass through the third quarter beat, Elanco is well positioned with momentum heading into 2027." exhibit
Q3 FY2026 "Credelio Quattro received positive opinion from European Medicines Agency for expansion into the EU; expect to launch in Q1 2027, ahead of the season" exhibit
Q3 FY2026 "Befrena™ access now open across clinics, including corporates, with all outstanding orders expected to be filled by next week and move into full launch in Q1 2027." exhibit
Q2 FY2026 "Document Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact: Tiffany Kanaga (765) 740-0314 or tiffany.kanaga@elancoah.com Media Contact: Colleen Parr Dekker (317) 989-7011 or colleen.dekker@elancoah.com Elanco Animal Health Reports Second Quarter 2026 Results Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target" exhibit
Q2 FY2026 "Improving year-end net leverage ratio target to approximately 3.0x Adjusted EBITDA Indianapolis, IN ( August 5, 2026 ) - Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the second quarter of 2026, provided guidance for the third quarter of 2026, and updated guidance for the full year 2026." exhibit
Q2 FY2026 "Financial Guidance Elanco is updating financial guidance for the full year 2026, summarized in the following table. 2026 Full Year (dollars in millions, except per share amounts) May Guidance August Guidance Revenue (1) $5,010 to $5,085 $5,090 to $5,140 Adjusted EBITDA $975 to $1,005 $1,010 to $1,035 Adjusted Earnings per Share $1.03 to $1.09 $1.10 to $1.16 (1) Revenue guidance excludes royalty revenue that was sold to a third party." exhibit
Q2 FY2026 ""Our faster than expected margin expansion includes good early progress on our Elanco Ascend productivity initiatives, on track to $200 million to $250 million in adjusted EBITDA net savings by 2030." exhibit
Q2 FY2026 "Excluding the impacts of foreign exchange rates, the AHV International acquisition that closed in April 2026, and royalty revenue sold to a third party, the company now expects revenue growth of 6% to 7% versus 5% to 7% previously." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ELAN
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ELAN

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

ELAN earnings date badge

HTML

<a href="https://veritasdata.dev/company/ELAN/"><img src="https://veritasdata.dev/embed/ELAN.svg" alt="ELAN earnings date" width="240" height="56"></a>

Markdown

[![ELAN earnings date](https://veritasdata.dev/embed/ELAN.svg)](https://veritasdata.dev/company/ELAN/)

Script

<script async src="https://veritasdata.dev/embed/ELAN.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ELAN"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.